WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 13 fonti

France becomes first EU country to reimburse Wegovy and Mounjaro | Euractiv

French health minister estimates annual cost at around €100 million

Raccontata da

it.euronews.com

zerohedge.com+1 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

euractiv.comStai leggendo1 g fa

France becomes first EU country to reimburse Wegovy and Mounjaro | Euractiv

French health minister estimates annual cost at around €100 million

Timeline cronologica

mercoledì 27 maggio 2026·franceinfo.fr
Les médicaments anti-obésité Wegovy et Mounjaro seront bientôt remboursés par la Sécurité sociale
Ces nouveaux traitements anti-obésité, Wegovy et Mounjaro, devenus des phénomènes planétaires, doivent être remboursés bientôt en France par l'Assurance maladie.
mercoledì 27 maggio 2026·thelocal.fr
France to expand access to weight-loss drugs for obesity patients
The French state will soon partially reimburse the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients, expanding access to the expensive drugs, two informed…

1 g fa

France to be first country in Europe to reimburse weight-loss drugs

France will cover the costs of weight-loss drugs from 15 June, according to the country's health minister.

Leggi questa versione → originale

France becomes first EU country to reimburse anti-obesity drugs

The move is estimated to cost the state around €100 million (US$116 million) annually at full roll-out.

Leggi questa versione → originale

rfi.fr1 g fa

France to start covering cost of weight-loss drugs for obese patients

France's public health system will soon start to cover most of the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients.

Leggi questa versione → originale

thelocal.fr2 g fa

France to expand access to weight-loss drugs for obesity patients

The French state will soon partially reimburse the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients, expanding access to the expensive drugs, two informed sources told AFP on Wednesday.

Leggi questa versione → originale

zerohedge.com21 h fa

France To Reimburse Patients For Anti-Obesity Drugs

"For the vast majority, it will be 100 percent reimbursement..."

Leggi questa versione → originale

mercoledì 27 maggio 2026·

rtl.fr

Wegovy, Mounjaro... Les médicaments contre l'obésité bientôt remboursés en France

Les traitements anti-obésité Wegovy et Mounjaro devraient être remboursés à partir de la mi-juin par l’Assurance maladie, dans un cadre très encadré.

giovedì 28 maggio 2026·

lemonde.fr

Les traitements contre l’obésité Wegovy et Mounjaro remboursés dès la mi-juin en France, dans un cadre contrôlé

Cette mesure, qui ne concernera que les patients atteints d’obésité massive sans comorbidité ou sévère avec comorbidité, devrait coûter « une centaine de millions d’euros » à…

giovedì 28 maggio 2026·

rtl.fr

"Une réponse à la hauteur de leur maladie" : ce que va changer le remboursement des médicaments anti-obésité Wegovy et Mounjaro pour les…

Le remboursement à hauteur de 65% des traitements anti-obésité Wegovy et Mounjaro est une véritable avancée pour les patients, qui n'avaient pas forcément les moyens de se les…

giovedì 28 maggio 2026·

franceinfo.fr

Les médicaments contre l'obésité Wegovy et Mounjaro seront officiellement remboursés dès la mi-juin, mais sous conditions

Ces deux traitements amaigrissants seront remboursés à 65% minimum pour les personnes atteintes d'obésité massive sans comorbidité ou sévère avec comorbidité.

giovedì 28 maggio 2026·

euractiv.com

France becomes first EU country to reimburse Wegovy and Mounjaro | Euractiv

French health minister estimates annual cost at around €100 million

giovedì 28 maggio 2026·

scmp.com

France becomes first EU country to reimburse anti-obesity drugs

The move is estimated to cost the state around €100 million (US$116 million) annually at full roll-out.

giovedì 28 maggio 2026·

lexpress.fr

Médicaments anti-obésité : le Wegovy et le Mounjaro bientôt remboursés par la Sécurité sociale

Dès la mi-juin, un million de Français en situation "d'obésité sévère" pourront bénéficier de la prise en charge de ces traitements amaigrissants.

giovedì 28 maggio 2026·

hotnews.ro

Prima țară din UE care subvenționează medicamentele împotriva obezității. Care sunt condițiile - HotNews.ro

Franța va rambursa costul tratamentelor pentru slăbit prescrise pacienților cu obezitate severă începând cu jumătatea lunii iunie, o premieră pentru o țară

giovedì 28 maggio 2026·

rfi.fr

France to start covering cost of weight-loss drugs for obese patients

France's public health system will soon start to cover most of the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients.

giovedì 28 maggio 2026·

euronews.com

France to be first country in Europe to reimburse weight-loss drugs

France will cover the costs of weight-loss drugs from 15 June, according to the country's health minister.

giovedì 28 maggio 2026·

it.euronews.com

Francia primo Paese in Europa a rimborsare farmaci dimagranti

La Francia rimborserà i farmaci dimagranti a partire dal 15 giugno, secondo quanto annunciato dal ministro della Salute.

venerdì 29 maggio 2026·

zerohedge.com

France To Reimburse Patients For Anti-Obesity Drugs

"For the vast majority, it will be 100 percent reimbursement..."

venerdì 29 maggio 2026·

www1.folha.uol.com.br

França vai reembolsar Mounjaro e Wegovy para pacientes com obesidade grave

Remédio da Eli Lilly é reembolsado no Reino Unido, na Grécia e na Suíça pelo período máximo de um ano

venerdì 29 maggio 2026·

lemonde.fr

Obésité : le remboursement sous conditions des médicaments Wegovy et Mounjaro, dès la mi-juin, saluée par patients et soignants

A partir du 15 juin, ces deux médicaments qui coûtent environ 300 euros par mois seront remboursés en France à hauteur de 65 % par l’Assurance maladie. Un million de personnes…